Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) FCF Margin: 2010-2025

Historic FCF Margin for Ironwood Pharmaceuticals (IRWD) over the last 15 years, with Sep 2025 value amounting to 38.98%.

  • Ironwood Pharmaceuticals' FCF Margin rose 2821.00% to 38.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.96%, marking a year-over-year decrease of 1276.00%. This contributed to the annual value of 29.43% for FY2024, which is 1194.00% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported FCF Margin of 38.98% as of Q3 2025, which was up 320.49% from -17.68% recorded in Q2 2025.
  • In the past 5 years, Ironwood Pharmaceuticals' FCF Margin ranged from a high of 82.95% in Q1 2021 and a low of -17.68% during Q2 2025.
  • Moreover, its 3-year median value for FCF Margin was 32.56% (2023), whereas its average is 32.82%.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' FCF Margin spiked by 3,020bps in 2021 and then plummeted by 5,307bps in 2025.
  • Over the past 5 years, Ironwood Pharmaceuticals' FCF Margin (Quarterly) stood at 55.02% in 2021, then surged by 1,887bps to 73.89% in 2022, then plummeted by 4,359bps to 30.30% in 2023, then tumbled by 1,350bps to 16.80% in 2024, then skyrocketed by 2,821bps to 38.98% in 2025.
  • Its FCF Margin stands at 38.98% for Q3 2025, versus -17.68% for Q2 2025 and 48.42% for Q1 2025.